340 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
AGN Allergan plc. $184.29 $62.56B N/A
Article Searches
Aldeyra Surges on Positive Dry Eye Study Data on Reproxalap http://www.zacks.com/stock/news/325203/aldeyra-surges-on-positive-dry-eye-study-data-on-reproxalap?cid=CS-ZC-FT-325203 Sep 27, 2018 - Aldeyra Therapeutics' (ALDX) dry eye candidate, reproxalap, achieves early onset of improvement in patients and a broad range of activity.
AbbVie Faces California Insurance Department Suit for Humira http://www.zacks.com/stock/news/323897/abbvie-faces-california-insurance-department-suit-for-humira?cid=CS-ZC-FT-323897 Sep 19, 2018 - AbbVie's (ABBV) shares fall on a lawsuit by California insurance department accusing it of giving illegal kickbacks to doctors for prescribing Humira.
Ironwood Stock Up, Heart Candidate Gets Fast Track Status http://www.zacks.com/stock/news/323183/ironwood-stock-up-heart-candidate-gets-fast-track-status?cid=CS-ZC-FT-323183 Sep 14, 2018 - The FDA confers fast track designation on Ironwood's (IRWD) praliciguat for the treatment of heart failure with preserved ejection fraction.
Is Allergan (AGN) a Great Stock for Value Investors? http://www.zacks.com/stock/news/323101/is-allergan-agn-a-great-stock-for-value-investors?cid=CS-ZC-FT-323101 Sep 14, 2018 - Let's see if Allergan (AGN) stock is a good choice for value-oriented investors right now from multiple angles.
Allergan PLC (AGN) CEO Brent Saunders Presents at 2018 Wells Fargo Healthcare Conference (Transcript) https://seekingalpha.com/article/4204308-allergan-plc-agn-ceo-brent-saunders-presents-2018-wells-fargo-healthcare-conference?source=feed_sector_healthcare Sep 05, 2018 - Allergan PLC (NYSE:AGN) 2018 Wells Fargo Healthcare Conference Call September 05, 2018 09:05 AM ET Executives Brent Saunders - Chief Executive Officer Analysts David Maris - Wells Fargo Securities Pre
BioDelivery (BDSI) Q2 Loss Narrows, Sales Miss, Shares Down http://www.zacks.com/stock/news/317417/biodelivery-bdsi-q2-loss-narrows-sales-miss-shares-down?cid=CS-ZC-FT-317417 Aug 10, 2018 - BioDelivery Sciences (BDSI) reports narrower-than-expected loss in Q2. Sales marginally miss the consensus mark.
Pharma Stock Roundup: NVO Q2 Earnings, JNJ, AGN & AZN's Pipeline Updates in Focus http://www.zacks.com/stock/news/317383/pharma-stock-roundup-nvo-q2-earnings-jnj-agn-azns-pipeline-updates-in-focus?cid=CS-ZC-FT-317383 Aug 10, 2018 - Novo Nordisk (NVO) reports strong Q2 results. J&J (JNJ) seeks approval for new dosing regimen of multiple myeloma drug. Allergan (AGN) exercises option to buy Editas' lead ocular candidate.
Drug Stocks to Report Earnings on Jul 26: AMGN, ALXN & More http://www.zacks.com/stock/news/313285/drug-stocks-to-report-earnings-on-jul-26-amgn-alxn-more?cid=CS-ZC-FT-313285 Jul 25, 2018 - Let's see how these five pharma/biotech stocks are poised ahead of their scheduled results on Jul 26.
Allergan's Depression Candidate Gets Fast Track Designation http://www.zacks.com/stock/news/313065/allergans-depression-candidate-gets-fast-track-designation?cid=CS-ZC-FT-313065 Jul 24, 2018 - The FDA grants fast track designation to Allergan's (AGN) AGN-241751, developed for the treatment of patients with major depressive disorder.
Allergan's AGN-241751 Fast Track'd in U.S. for MDD https://seekingalpha.com/news/3372325-allergans-agnminus-241751-fast-trackd-u-s-mdd?source=feed_news_all Jul 23, 2018 - The FDA designates Allergan's (NYSE:AGN) Phase 2-stage AGN-241751 for Fast Track review for the treatment of major depressive disorder (MDD).The company acquired the NMDAR modulator from Aptin

Pages: 1...4567891011121314...34

<<<Page 9>